<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="5526617c-c7b9-4556-886d-729bbabbc566"><labelDrug name="SAMSCA"><Normalization><mmtx cui="C2710117" preferredWord="Samsca" semType="phsu, orch"/></Normalization></labelDrug><generic name="tolvaptan"/><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.1" text="Drug Label for drug brand SAMSCA, containing tolvaptan." type="negative"><entity charOffset="45:54" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.1.e.0" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="tolvaptan." preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.1.e.1" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand SAMSCA," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="26:32" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.1.e.2" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="Drug Label for drug brand SAMSCA," preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.1.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.1.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.1.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.1.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.1.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.1.e.2"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.3" text="SAMSCA should be initiated and re-initiated in patients only in a hospital where serum sodium can be monitored closely." type="negative"><entity charOffset="87:93" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.3.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="in a hospital where serum sodium" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="0:6" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.3.e.1" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.3.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.3.e.0"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.8" text="&lt;item&gt;SAMSCA should be initiated and re-initiated in patients only in a hospital where serum sodium can be monitored closely." type="negative"><entity charOffset="93:99" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.8.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="in a hospital where serum sodium" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="6:12" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.8.e.1" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="&gt;SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.8.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.8.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.12" lineNumber="24" text="&lt;main&gt;SAMSCA is contraindicated in the following conditions:" type="regular"><entity charOffset="16:31" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.12.e.1" text="contraindicated" type="Caution_Interaction"/><entity charOffset="16:31" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.12.e.2" text="contraindicated" type="SPAN"/><entity charOffset="6:12" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.12.e.3" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="&gt;SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.12.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.12.e.1"><relations><relation type="hasSeverity"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.12.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.12.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.16.e.0"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.19" text="SAMSCA has not been studied in a setting of urgent need to raise serum sodium acutely." type="negative"><entity charOffset="71:77" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.19.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="serum sodium acutely." preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="0:6" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.19.e.1" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.19.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.19.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.25" lineNumber="55" text="Ketoconazole 200 mg administered with tolvaptan increased tolvaptan exposure by 5 fold. " type="regular"><entity charOffset="48:57|68:76" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.25.e.1" text="increased exposure" type="Increase_Interaction"/><entity charOffset="0:12" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.25.e.2" text="Ketoconazole" type="Drug"><Normalization><mmtx cui="C0992485" phraseText="Ketoconazole 200 mg" preferredWord="Ketoconazole 200 MG" semType="clnd"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="58:67" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.25.e.3" text="tolvaptan" type="Drug"><Normalization><mmtx cui="C1176308" phraseText="tolvaptan exposure by 5 fold." preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.25.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.25.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.25.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.25.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.25.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.25.e.3" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.25.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27" text="There is not adequate experience to define the dose adjustment that would be needed to allow safe use of tolvaptan with strong CYP 3A inhibitors such as clarithromycin, ketoconazole, itraconazole, ritonavir, indinavir, nelfinavir, saquinavir, nefazodone, and telithromycin." type="negative"><entity charOffset="197:206" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.0" text="ritonavir" type="Biomedical_Entity"><Normalization><mmtx cui="C0292818" phraseText="ritonavir," preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><entity charOffset="208:217" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.1" text="indinavir" type="Biomedical_Entity"><Normalization><mmtx cui="C0376637" phraseText="indinavir," preferredWord="Indinavir" semType="phsu, orch"/><RxNorm RxCui="114289"/></Normalization></entity><entity charOffset="219:229" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.2" text="nelfinavir" type="Biomedical_Entity"><Normalization><mmtx cui="C0525005" phraseText="nelfinavir," preferredWord="Nelfinavir" semType="phsu, orch"/><RxNorm RxCui="266565"/></Normalization></entity><entity charOffset="243:253" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.3" text="nefazodone" type="Biomedical_Entity"><Normalization><mmtx cui="C0068485" phraseText="nefazodone," preferredWord="nefazodone" semType="phsu, orch"/><RxNorm RxCui="31565"/></Normalization></entity><entity charOffset="231:241" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.4" text="saquinavir" type="Biomedical_Entity"><Normalization><mmtx cui="C0286738" phraseText="saquinavir," preferredWord="Saquinavir" semType="phsu, orch"/><RxNorm RxCui="859857"/></Normalization></entity><entity charOffset="169:181" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.5" text="ketoconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0022625" phraseText="ketoconazole," preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="183:195" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.6" text="itraconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0064113" phraseText="itraconazole," preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="153:167" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.7" text="clarithromycin" type="Biomedical_Entity"><Normalization><mmtx cui="C0055856" phraseText="such as clarithromycin," preferredWord="Clarithromycin" semType="orch, antb"/><RxNorm RxCui="21212"/></Normalization></entity><entity charOffset="105:114" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.8" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="safe use of tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="259:272" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.9" text="telithromycin" type="Biomedical_Entity"><Normalization><mmtx cui="C0907410" phraseText="telithromycin." preferredWord="telithromycin" semType="orch, antb"/><RxNorm RxCui="274786"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.6" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.7" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.8" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.9"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.6" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.7" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.8" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.9"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.6" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.7" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.8" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.9"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.6" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.7" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.8" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.9"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.6" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.7" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.8" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.9"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.6"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.7" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.5"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.8" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.5"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.9"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.7" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.6"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.8" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.6"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.6" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.9"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.8" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.7"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.7" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.9"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.8" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.27.e.9"/></sentence><sentence biomedicalEntities="1" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.36" lineNumber="70" text="&lt;item&gt;Avoid use with hypertonic saline (5.4)" type="irregular"><entity charOffset="6:11" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.36.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="21:38" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.36.e.2" text="hypertonic saline" type="Drug"><Normalization><mmtx cui="C0036085" phraseText="use with hypertonic saline" preferredWord="Saline Solution, Hypertonic" semType="inch, phsu"/><RxNorm RxCui="5592"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.36.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.36.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.36.e.2"/></relation><relation type="hasObject"><labelDrug text="SAMSCA"/><normalization><mmtx><preferredWord>Samsca</preferredWord><phraseText>&gt;SAMSCA</phraseText><cuiCode>C2710117</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.36.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37" lineNumber="72" text="&lt;item&gt;Avoid use with CYP 3A inducers and moderate CYP 3A inhibitors (5.5)" type="irregular"><entity charOffset="6:11" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="41:67" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37.e.2" text="moderate CYP 3A inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="855444"/></Normalization></entity><entity charOffset="21:36" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37.e.3" text="CYP 3A inducers" type="Drug_Class"><Normalization><RxNorm RxCui="24493"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37.e.3"/></relation><relation type="hasObject"><labelDrug text="SAMSCA"/><normalization><mmtx><preferredWord>Samsca</preferredWord><phraseText>&gt;SAMSCA</phraseText><cuiCode>C2710117</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.37.e.3"/></sentence><sentence biomedicalEntities="1" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.38" lineNumber="74" text="&lt;item&gt;Consider dose reduction if co-administered with P-gp inhibitors (5.5)" type="irregular"><entity charOffset="15:29" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.38.e.1" text="dose reduction" type="Increase_Interaction"/><entity charOffset="54:69" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.38.e.2" text="P-gp inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="71576"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.38.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.38.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.38.e.2"/></relation><relation type="hasObject"><labelDrug text="SAMSCA"/><normalization><mmtx><preferredWord>Samsca</preferredWord><phraseText>&gt;SAMSCA</phraseText><cuiCode>C2710117</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.38.e.2"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45" text="In controlled clinical trials in which tolvaptan was administered in titrated doses starting at 15 mg once daily, 7% of tolvaptan-treated subjects with a serum sodium 130 mEq/L had an increase in serum sodium greater than 8 mEq/L at approximately 8 hours and 2% had an increase greater than 12 mEq/L at 24 hours. " type="negative"><entity charOffset="160:166" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="with a serum sodium 130 mEq/L" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="202:208" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.1" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="an increase in serum sodium" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="120:129" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.2" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="7% of tolvaptan-treated subjects" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="39:48" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.3" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="in which tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.45.e.1"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.48" text="Patients treated with SAMSCA should be monitored to assess serum sodium concentrations and neurologic status, especially during initiation and after titration. " type="negative"><entity charOffset="65:71" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.48.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="serum sodium concentrations" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="22:28" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.48.e.1" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="treated with SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.48.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.48.e.0"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.50" text="In patients receiving SAMSCA who develop too rapid a rise in serum sodium, discontinue or interrupt treatment with SAMSCA and consider administration of hypotonic fluid. " type="negative"><entity charOffset="115:121" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.50.e.0" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="treatment with SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><entity charOffset="22:28" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.50.e.1" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><entity charOffset="67:73" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.50.e.2" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="a rise in serum sodium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.50.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.50.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.50.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.50.e.2"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.51" text="Fluid restriction during the first 24 hours of therapy with SAMSCA may increase the likelihood of overly-rapid correction of serum sodium, and should generally be avoided." type="negative"><entity charOffset="131:137" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.51.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="the likelihood of overly-rapid correction of serum sodium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="60:66" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.51.e.1" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="with SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.51.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.51.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62" lineNumber="94" text="Dehydration and hypovolemia can occur, especially in potentially volume-depleted patients receiving diuretics or those who are fluid restricted. " type="irregular"><entity charOffset="16:27" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.e.1" text="hypovolemia" type="Specific_Interaction"/><entity charOffset="65:89" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.e.2" text="volume-depleted patients" type="SPAN"/><entity charOffset="100:109" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.e.3" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.e.5" text="Dehydration" type="Specific_Interaction"><Normalization><mmtx cui="C0011175" phraseText="Dehydration" preferredWord="Dehydration" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.e.1"><relations><relation type="hasContext"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.61" text="SAMSCA therapy induces copious aquaresis, which is normally partially offset by fluid intake. "><entity charOffset="0:6" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.61.e.0" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA therapy" preferredWord="Samsca" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.ddi.2"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.e.5"><relations><relation type="hasContext"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.61" text="SAMSCA therapy induces copious aquaresis, which is normally partially offset by fluid intake. "><entity charOffset="0:6" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.61.e.0" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA therapy" preferredWord="Samsca" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.62.e.3"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.64" text="In patients receiving SAMSCA who develop medically significant signs or symptoms of hypovolemia, interrupt or discontinue SAMSCA therapy and provide supportive care with careful management of vital signs, fluid balance and electrolytes. " type="negative"><entity charOffset="223:235" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.64.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="electrolytes." preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="122:128" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.64.e.1" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA therapy" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><entity charOffset="22:28" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.64.e.2" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.64.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.64.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.64.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.64.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.68" lineNumber="98" text="Concomitant use with hypertonic saline is not recommended." type="irregular"><entity charOffset="42:57" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.68.e.1" text="not recommended" type="Caution_Interaction"/><entity charOffset="21:38" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.68.e.2" text="hypertonic saline" type="Drug"><Normalization><mmtx cui="C0036085" phraseText="Concomitant use with hypertonic saline" preferredWord="Saline Solution, Hypertonic" semType="inch, phsu"/><RxNorm RxCui="5592"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.68.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.68.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.68.e.2"/></relation><relation type="hasObject"><labelDrug text="SAMSCA"/><normalization><mmtx><preferredWord>Samsca</preferredWord><phraseText>&gt;SAMSCA</phraseText><cuiCode>C2710117</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.68.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.73" lineNumber="104" text="CYP 3A inhibitors can lead to a marked increase in tolvaptan concentrations see Dosage and Administration (2.3), Drug Interactions (7.1). " type="regular"><entity charOffset="39:50|61:75" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.73.e.1" text="increase in concentrations" type="Increase_Interaction"/><entity charOffset="0:17" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.73.e.2" text="CYP 3A inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="24493"/></Normalization></entity><entity charOffset="51:60" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.73.e.3" text="tolvaptan" type="Drug"><Normalization><mmtx cui="C1176308" phraseText="in tolvaptan concentrations" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.73.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.73.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.73.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.73.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.73.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.73.e.3" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.73.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74" lineNumber="104" text="Do not use SAMSCA with strong inhibitors of CYP 3A see Contraindications (4.4) and avoid concomitant use with moderate CYP 3A inhibitors." type="regular"><entity charOffset="0:10" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.1" text="Do not use" type="Caution_Interaction"/><entity charOffset="23:50" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.2" text="strong inhibitors of CYP 3A" type="Drug_Class"><Normalization><RxNorm RxCui="608507"/></Normalization></entity><entity charOffset="11:17" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.3" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA with strong inhibitors of CYP 3A" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><entity charOffset="83:88" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.5" text="avoid" type="Caution_Interaction"/><entity charOffset="110:136" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.6" text="moderate CYP 3A inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="855444"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.1"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.ddi.2"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.5"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.2" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.6" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.74.e.5" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="11" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76" lineNumber="106" text="Avoid co-administration of CYP 3A inducers (e.g., rifampin, rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine, St. John's Wort) with SAMSCA, as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="216:225" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.8" text="tolvaptan" type="Drug"/><antecedentEntity charOffset="145-151" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.10" text="SAMSCA" type="Drug"/></anaphoraRelation><entity charOffset="123:138" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.0" text="St. John's Wort" type="Drug"><Normalization><mmtx cui="C0813171" phraseText="St. John's Wort" preferredWord="ST. JOHN'S WORT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="669620"/></Normalization></entity><entity charOffset="27:42" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.2" text="CYP 3A inducers" type="Drug_Class"><Normalization><RxNorm RxCui="24493"/></Normalization></entity><entity charOffset="50:58" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.3" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="rifampin," preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="60:69" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.5" text="rifabutin" type="Drug"><Normalization><mmtx cui="C0140575" phraseText="rifabutin," preferredWord="Rifabutin" semType="orch, antb"/><RxNorm RxCui="55672"/></Normalization></entity><entity charOffset="175:212" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.7" text="reduction in the plasma concentration" type="Decrease_Interaction"/><entity charOffset="216:225" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.8" text="tolvaptan" type="Drug"><Normalization><mmtx cui="C1176308" phraseText="of tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="145:151" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.10" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="with SAMSCA," preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><entity charOffset="230:253" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.12" text="decreased effectiveness" type="Decrease_Interaction"/><entity charOffset="257:263" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.13" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="decreased effectiveness of SAMSCA treatment." preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><entity charOffset="71:81" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.15" text="rifapentin" type="Drug"><Normalization><RxNorm RxCui="35617"/></Normalization></entity><entity charOffset="83:95" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.17" text="barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="97:106" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.19" text="phenytoin" type="Drug"><Normalization><mmtx cui="C0031507" phraseText="phenytoin," preferredWord="Phenytoin" semType="phsu, orch"/><RxNorm RxCui="8183"/></Normalization></entity><entity charOffset="108:121" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.21" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="carbamazepine," preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.3" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.2"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.5" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.2"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.15" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.2"/><classClassMembership drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.17"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.19" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.2"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.21" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.2"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.0" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.2"/><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.7"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.8"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.ddi.2"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.12"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.13"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.8" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.7" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.13" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.76.e.12" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.77" lineNumber="106" text="If co-administered with CYP 3A inducers, the dose of SAMSCA may need to be increased see Dosage and Administration (2.3), Drug Interactions (7.1)." type="regular"><entity charOffset="45:49|75:84" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.77.e.1" text="dose increased" type="Caution_Interaction"/><entity charOffset="53:59" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.77.e.2" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="the dose of SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><entity charOffset="24:39" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.77.e.3" text="CYP 3A inducers" type="Drug_Class"><Normalization><RxNorm RxCui="24493"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.77.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.77.e.1"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.77.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.77.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.77.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.77.e.2" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.77.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79" lineNumber="108" text="The dose of SAMSCA may have to be reduced when SAMSCA is co-administered with P-gp inhibitors, e.g., cyclosporine see Dosage and Administration (2.3), Drug Interactions (7.1)." type="regular"><entity charOffset="78:93" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.1" text="P-gp inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="71576"/></Normalization></entity><entity charOffset="101:113" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.2" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="4:8|34:41" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.4" text="dose reduced" type="Caution_Interaction"/><entity charOffset="12:18" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.5" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="The dose of SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.2" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.1"/><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.4"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.1" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.79.e.4" type="Caution_Interaction"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.81" text="Treatment with tolvaptan is associated with an acute reduction of the extracellular fluid volume which could result in increased serum potassium. " type="negative"><entity charOffset="135:144" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.81.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="result in increased serum potassium." preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="15:24" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.81.e.1" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="Treatment with tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.81.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.81.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.82" lineNumber="112" text="Serum potassium levels should be monitored after initiation of tolvaptan treatment in patients with a serum potassium 5 mEq/L as well as those who are receiving drugs known to increase serum potassium levels." type="regular"><entity charOffset="33:42" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.82.e.1" text="monitored" type="Caution_Interaction"/><entity charOffset="63:72" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.82.e.2" text="tolvaptan" type="Drug"><Normalization><mmtx cui="C1176308" phraseText="monitored after initiation of tolvaptan treatment" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="161:207" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.82.e.3" text="drugs known to increase serum potassium levels" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="receiving drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0597277" phraseText="serum potassium levels." preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C2946261" phraseText="serum potassium levels." preferredWord="Level" semType="phsu"/><mmtx cui="C0597277" phraseText="serum potassium levels." preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C2946261" phraseText="serum potassium levels." preferredWord="Level" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.82.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.82.e.1"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.82.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.82.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.82.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.82.e.3" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.82.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88" lineNumber="121" text="Co-administration of SAMSCA and ketoconazole 200 mg daily results in a 5 fold increase in exposure to tolvaptan. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="102:111" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.2" text="tolvaptan" type="Drug"/><antecedentEntity charOffset="21-27" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.5" text="SAMSCA" type="Drug"/></anaphoraRelation><entity charOffset="78:98" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.1" text="increase in exposure" type="Increase_Interaction"/><entity charOffset="102:111" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.2" text="tolvaptan" type="Drug"><Normalization><mmtx cui="C1176308" phraseText="to tolvaptan." preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="32:44" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.3" text="ketoconazole" type="Drug"><Normalization><mmtx cui="C0992485" phraseText="ketoconazole 200 mg daily" preferredWord="Ketoconazole 200 MG" semType="clnd"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="21:27" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.5" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="Co-administration of SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.1"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.2" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.88.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="10" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89" lineNumber="121" text="Co-administration of SAMSCA with 400 mg ketoconazole daily or with other strong CYP 3A inhibitors (e.g., clarithromycin, itraconazole, telithromycin, saquinavir, nelfinavir, ritonavir and nefazodone) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="283:292" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.17" text="tolvaptan" type="Drug"/><antecedentEntity charOffset="21-27" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.19" text="SAMSCA" type="Drug"/></anaphoraRelation><entity charOffset="73:97" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.1" text="strong CYP 3A inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="608507"/></Normalization></entity><entity charOffset="105:119" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.2" text="clarithromycin" type="Drug"><Normalization><mmtx cui="C0055856" phraseText="clarithromycin," preferredWord="Clarithromycin" semType="orch, antb"/><RxNorm RxCui="21212"/></Normalization></entity><entity charOffset="121:133" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.4" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="itraconazole," preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="135:148" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.6" text="telithromycin" type="Drug"><Normalization><mmtx cui="C0907410" phraseText="telithromycin," preferredWord="telithromycin" semType="orch, antb"/><RxNorm RxCui="274786"/></Normalization></entity><entity charOffset="150:160" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.8" text="saquinavir" type="Drug"><Normalization><mmtx cui="C0286738" phraseText="saquinavir," preferredWord="Saquinavir" semType="phsu, orch"/><RxNorm RxCui="859857"/></Normalization></entity><entity charOffset="162:172" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.10" text="nelfinavir" type="Drug"><Normalization><mmtx cui="C0525005" phraseText="nelfinavir," preferredWord="Nelfinavir" semType="phsu, orch"/><RxNorm RxCui="266565"/></Normalization></entity><entity charOffset="174:183" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.12" text="ritonavir" type="Drug"><Normalization><mmtx cui="C0292818" phraseText="ritonavir" preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><entity charOffset="188:198" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.14" text="nefazodone" type="Drug"><Normalization><mmtx cui="C0068485" phraseText="nefazodone" preferredWord="nefazodone" semType="phsu, orch"/><RxNorm RxCui="31565"/></Normalization></entity><entity charOffset="271:282|293:301" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.16" text="increase in exposure" type="Increase_Interaction"/><entity charOffset="283:292" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.17" text="tolvaptan" type="Drug"><Normalization><mmtx cui="C1176308" phraseText="an even greater increase in tolvaptan exposure." preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="21:27" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.19" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="Co-administration of SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.2" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.1"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.4" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.1"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.6" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.1"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.8" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.1"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.10" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.1"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.12" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.1"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.14" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.1"/><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.16"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.17"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.17" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.89.e.16" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.90" lineNumber="121" text="Thus, SAMSCA and strong CYP 3A inhibitors should not be co-administered see Dosage and Administration (2.3) and Contraindications (4.4)." type="regular"><entity charOffset="49:71" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.90.e.1" text="not be co-administered" type="Caution_Interaction"/><entity charOffset="6:12" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.90.e.2" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><entity charOffset="17:41" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.90.e.3" text="strong CYP 3A inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="608507"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.90.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.90.e.1"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.90.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.90.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.90.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.90.e.3" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.90.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92" text="The impact of moderate CYP 3A inhibitors (e.g., erythromycin, fluconazole, aprepitant, diltiazem and verapamil) on the exposure to co-administered tolvaptan has not been assessed. " type="negative"><entity charOffset="62:73" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.0" text="fluconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0016277" phraseText="fluconazole," preferredWord="Fluconazole" semType="phsu, orch"/><RxNorm RxCui="4450"/></Normalization></entity><entity charOffset="48:60" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.1" text="erythromycin" type="Biomedical_Entity"><Normalization><mmtx cui="C0014806" phraseText="erythromycin," preferredWord="Erythromycin" semType="orch, antb"/><RxNorm RxCui="4053"/></Normalization></entity><entity charOffset="147:156" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.2" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="101:110" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.3" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="87:96" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.4" text="diltiazem" type="Biomedical_Entity"><Normalization><mmtx cui="C0012373" phraseText="diltiazem" preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="75:85" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.5" text="aprepitant" type="Biomedical_Entity"><Normalization><mmtx cui="C1176306" phraseText="aprepitant," preferredWord="aprepitant" semType="phsu, orch"/><RxNorm RxCui="358255"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.5"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.5"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.92.e.4"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.93" text="A substantial increase in the exposure to tolvaptan would be expected when SAMSCA is co-administered with moderate CYP 3A inhibitors. " type="negative"><entity charOffset="75:81" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.93.e.0" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><entity charOffset="42:51" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.93.e.1" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="to tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.93.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.93.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.94" lineNumber="123" text="Co-administration of SAMSCA with moderate CYP3A inhibitors should therefore generally be avoided see Dosage and Administration (2.3) and Warnings and Precautions (5.5)." type="regular"><entity charOffset="89:96" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.94.e.1" text="avoided" type="Caution_Interaction"/><entity charOffset="33:58" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.94.e.2" text="moderate CYP3A inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="855444"/></Normalization></entity><entity charOffset="21:27" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.94.e.3" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="Co-administration of SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.94.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.94.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.94.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.94.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.94.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.94.e.2" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.94.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96" lineNumber="125" text="Co-administration of grapefruit juice and SAMSCA results in a 1.8 fold increase in exposure to tolvaptan see Dose and Administration (2.3) and Warnings and Precautions (5.5)." type="regular"><anaphoraRelation><anaphoraEntity charOffset="95:104" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.3" text="tolvaptan" type="Drug"/><antecedentEntity charOffset="42-48" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.5" text="SAMSCA" type="Drug"/></anaphoraRelation><entity charOffset="71:91" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.1" text="increase in exposure" type="Increase_Interaction"/><entity charOffset="21:37" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.2" text="grapefruit juice" type="Substance"><Normalization><mmtx cui="C0440280" phraseText="Co-administration of grapefruit juice" preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><entity charOffset="95:104" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.3" text="tolvaptan" type="Drug"><Normalization><mmtx cui="C1176308" phraseText="to tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="42:48" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.5" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.3" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.96.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98" lineNumber="127" text="Reduction in the dose of SAMSCA may be required in patients concomitantly treated with P-gp inhibitors, such as e.g., cyclosporine, based on clinical response see Dose and Administration (2.3) and Warnings and Precautions (5.5)." type="regular"><entity charOffset="87:102" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.1" text="P-gp inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="71576"/></Normalization></entity><entity charOffset="118:130" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.2" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="cyclosporine," preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="0:21" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.4" text="Reduction in the dose" type="Caution_Interaction"/><entity charOffset="25:31" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.5" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="Reduction in the dose of SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.2" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.1"/><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.4"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.1" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.98.e.4" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101" lineNumber="129" text="Co-administration of rifampin and SAMSCA reduces exposure to tolvaptan by 85%. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="61:70" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.2" text="tolvaptan" type="Drug"/><antecedentEntity charOffset="34-40" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.5" text="SAMSCA" type="Drug"/></anaphoraRelation><entity charOffset="41:57" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.1" text="reduces exposure" type="Decrease_Interaction"/><entity charOffset="61:70" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.2" text="tolvaptan" type="Drug"><Normalization><mmtx cui="C1176308" phraseText="exposure to tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="21:29" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.3" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="Co-administration of rifampin" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="34:40" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.5" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.1"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.2" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.101.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="8" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102" lineNumber="129" text="Therefore, the expected clinical effects of SAMSCA in the presence of rifampin and other inducers (e.g., rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine and St. John's Wort) may not be observed at the usual dose levels of SAMSCA. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.100" Text="Rifampin is an inducer of CYP 3A and P-gp. "/><anaphoraEntity charOffset="89:97" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.1" text="inducers" type="Expression"/><antecedentEntity charOffset="15:32" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.100.e.0" text="inducer of CYP 3A" type="Drug_Class"/></anaphoraRelation><entity charOffset="171:173" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.3" text="St" type="Drug"><Normalization><mmtx cui="C0813171" phraseText="St. John's Wort" preferredWord="ST. JOHN'S WORT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="669620"/></Normalization></entity><entity charOffset="175:186" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.4" text="John's Wort" type="SPAN"/><entity charOffset="105:114" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.6" text="rifabutin" type="Drug"><Normalization><mmtx cui="C0140575" phraseText="rifabutin," preferredWord="Rifabutin" semType="orch, antb"/><RxNorm RxCui="55672"/></Normalization></entity><entity charOffset="116:126" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.8" text="rifapentin" type="Drug"><Normalization><RxNorm RxCui="35617"/></Normalization></entity><entity charOffset="128:140" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.10" text="barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="142:151" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.12" text="phenytoin" type="Drug"><Normalization><mmtx cui="C0031507" phraseText="phenytoin," preferredWord="Phenytoin" semType="phsu, orch"/><RxNorm RxCui="8183"/></Normalization></entity><entity charOffset="153:166" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.14" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="carbamazepine" preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><entity charOffset="15:40|192:207" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.17" text="expected clinical effects not be observed" type="Specific_Interaction"/><entity charOffset="70:78" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.18" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="of rifampin" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="44:50" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.19" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="the expected clinical effects of SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.6" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.1"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.8" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.1"/><classClassMembership drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.10"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.12" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.1"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.14" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.1"/><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.3" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.1"/><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.17"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.18"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.19"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.19" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.18" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.17" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.19" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.1" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.17" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.18" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.103" lineNumber="129" text="The dose of SAMSCA may have to be increased Dosage and Administration (2.3) and Warnings and Precautions (5.5)." type="irregular"><entity charOffset="4:8|34:43" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.103.e.1" text="dose increased" type="Caution_Interaction"/><entity charOffset="12:18" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.103.e.2" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="The dose of SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.103.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.103.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102" text="Therefore, the expected clinical effects of SAMSCA in the presence of rifampin and other inducers (e.g., rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine and St. John's Wort) may not be observed at the usual dose levels of SAMSCA. "><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.18"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.103.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102" text="Therefore, the expected clinical effects of SAMSCA in the presence of rifampin and other inducers (e.g., rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine and St. John's Wort) may not be observed at the usual dose levels of SAMSCA. "><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.102.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104" text="Lovastatin, Digoxin, Furosemide, and Hydrochlorothiazide" type="negative"><entity charOffset="12:19" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.0" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="Digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.1" text="lovastatin" type="Biomedical_Entity"><Normalization><mmtx cui="C0024027" phraseText="Lovastatin," preferredWord="Lovastatin" semType="phsu, orch"/><RxNorm RxCui="6472"/></Normalization></entity><entity charOffset="21:31" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.2" text="furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016860" phraseText="Furosemide," preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="37:56" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.104.e.3"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105" text="Co-administration of lovastatin, digoxin, furosemide, and hydrochlorothiazide with SAMSCA has no clinically relevant impact on the exposure to tolvaptan." type="negative"><entity charOffset="143:152" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.0" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="to tolvaptan." preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="58:77" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide with SAMSCA" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="42:52" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.2" text="furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016860" phraseText="furosemide," preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="21:31" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.3" text="lovastatin" type="Biomedical_Entity"><Normalization><mmtx cui="C0024027" phraseText="Co-administration of lovastatin," preferredWord="Lovastatin" semType="phsu, orch"/><RxNorm RxCui="6472"/></Normalization></entity><entity charOffset="83:89" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.4" text="samsca" type="Biomedical_Entity"><Normalization><mmtx cui="C2710117" phraseText="hydrochlorothiazide with SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><entity charOffset="33:40" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.5" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.5"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.105.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109" lineNumber="136" text="Co-administration of SAMSCA with digoxin increased digoxin AUC by 20% and Cmax by 30%." type="regular"><entity charOffset="41:50|59:62" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.1" text="increased AUC" type="Increase_Interaction"/><entity charOffset="21:27" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.2" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="Co-administration of SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><entity charOffset="51:58" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.3" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="digoxin AUC by 20%" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="41:50|74:78" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.5" text="increased Cmax" type="Increase_Interaction"/><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.ddi.2"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.3" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.109.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110" text="Warfarin, Amiodarone, Furosemide, and Hydrochlorothiazide" type="negative"><entity charOffset="38:57" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.1" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="Warfarin," preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="22:32" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.2" text="furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016860" phraseText="Furosemide," preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="10:20" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.3" text="amiodarone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002598" phraseText="Amiodarone," preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.110.e.2"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111" text="Co-administration of tolvaptan does not appear to alter the pharmacokinetics of warfarin, furosemide, hydrochlorothiazide, or amiodarone (or its active metabolite, desethylamiodarone) to a clinically significant degree." type="negative"><entity charOffset="126:136" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.0" text="amiodarone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002598" phraseText="amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><entity charOffset="80:88" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.1" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="the pharmacokinetics of warfarin," preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="164:182" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.2" text="desethylamiodarone" type="Biomedical_Entity"><Normalization><mmtx cui="C0057522" phraseText="desethylamiodarone" preferredWord="desethylamiodarone" semType="phsu, orch"/><RxNorm RxCui="22626"/></Normalization></entity><entity charOffset="102:121" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="21:30" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.4" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="Co-administration of tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="90:100" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.5" text="furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016860" phraseText="furosemide," preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.5"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.111.e.5"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114" lineNumber="140" text="Co-administration of lovastatin and SAMSCA increases the exposure to lovastatin and its active metabolite lovastatin- hydroxyacid by factors of 1.4 and 1.3, respectively. " type="regular"><entity charOffset="43:65" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.1" text="increases the exposure" type="Increase_Interaction"/><entity charOffset="106:129" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.2" text="lovastatin- hydroxyacid" type="Drug"><Normalization><mmtx cui="C0024027" phraseText="its active metabolite lovastatin- hydroxyacid by factors of 1.4" preferredWord="Lovastatin" semType="phsu, orch"/><RxNorm RxCui="6472"/></Normalization></entity><entity charOffset="69:79" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.3" text="lovastatin" type="Drug"><Normalization><mmtx cui="C0024027" phraseText="the exposure to lovastatin" preferredWord="Lovastatin" semType="phsu, orch"/><RxNorm RxCui="6472"/></Normalization></entity><entity charOffset="36:42" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.4" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA" preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.1"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.3" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.2" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.114.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.117" text="Tolvaptan produces a greater 24 hour urine volume/excretion rate than does furosemide or hydrochlorothiazide. " type="negative"><entity charOffset="89:108" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.117.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="75:85" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.117.e.1" text="furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016860" phraseText="furosemide" preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.117.e.2" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="Tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.117.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.117.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.117.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.117.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.117.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.117.e.1"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118" text="Concomitant administration of tolvaptan with furosemide or hydrochlorothiazide results in a 24 hour urine volume/excretion rate that is similar to the rate after tolvaptan administration alone." type="negative"><entity charOffset="59:78" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide results in a 24 hour urine volume/excretion rate" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="162:171" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.1" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="after tolvaptan administration" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="30:39" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.2" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="Concomitant administration of tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="45:55" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.3" text="furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016860" phraseText="with furosemide" preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.1"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.118.e.3"/></sentence><sentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119" text="Although specific interaction studies were not performed, in clinical studies tolvaptan was used concomitantly with beta-blockers, angiotensin receptor blockers, angiotensin converting enzyme inhibitors and potassium sparing diuretics. " type="negative"><entity charOffset="116:129" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.0" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="concomitantly with beta-blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="78:87" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.1" text="tolvaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176308" phraseText="in clinical studies tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="162:202" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.2" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="angiotensin converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="207:234" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.3" text="potassium sparing diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0304490" phraseText="potassium sparing diuretics." preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="131:160" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.4" text="angiotensin receptor blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0815017" phraseText="angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.0"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.0" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.1" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.3"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.2"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.119.e.3"/></sentence><sentence biomedicalEntities="4" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120" lineNumber="143" text="Adverse reactions of hyperkalemia were approximately 1-2% higher when tolvaptan was administered with angiotensin receptor blockers, angiotensin converting enzyme inhibitors and potassium sparing diuretics compared to administration of these medications with placebo. " type="regular"><entity charOffset="21:33" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.1" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="102:131" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.2" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="administered with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="administered with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="70:79" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.3" text="tolvaptan" type="Drug"><Normalization><mmtx cui="C1176308" phraseText="tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="178:205" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.4" text="potassium sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="potassium sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="133:173" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.5" text="angiotensin converting enzyme inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="angiotensin converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.2" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.4" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.5" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.4"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.5"/><pair ddi="false" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.5" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.4"/></sentence><sentence biomedicalEntities="0" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.121" lineNumber="143" text="Serum potassium levels should be monitored during concomitant drug therapy." type="irregular"><entity charOffset="33:42" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.121.e.1" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.121.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.121.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120" text="Adverse reactions of hyperkalemia were approximately 1-2% higher when tolvaptan was administered with angiotensin receptor blockers, angiotensin converting enzyme inhibitors and potassium sparing diuretics compared to administration of these medications with placebo. "><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.2"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120" text="Adverse reactions of hyperkalemia were approximately 1-2% higher when tolvaptan was administered with angiotensin receptor blockers, angiotensin converting enzyme inhibitors and potassium sparing diuretics compared to administration of these medications with placebo. "><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.3"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120" text="Adverse reactions of hyperkalemia were approximately 1-2% higher when tolvaptan was administered with angiotensin receptor blockers, angiotensin converting enzyme inhibitors and potassium sparing diuretics compared to administration of these medications with placebo. "><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.4"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120" text="Adverse reactions of hyperkalemia were approximately 1-2% higher when tolvaptan was administered with angiotensin receptor blockers, angiotensin converting enzyme inhibitors and potassium sparing diuretics compared to administration of these medications with placebo. "><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.120.e.5"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122" lineNumber="144" text="As a V2-receptor antagonist, tolvaptan may interfere with the V2-agonist activity of desmopressin (dDAVP). " type="regular"><entity charOffset="5:27" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.1" text="V2-receptor antagonist" type="Drug_Class"><Normalization><RxNorm RxCui="154375"/></Normalization></entity><entity charOffset="29:38" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.2" text="tolvaptan" type="Drug"><Normalization><mmtx cui="C1176308" phraseText="tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="358257"/></Normalization></entity><entity charOffset="43:81" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.4" text="interfere with the V2-agonist activity" type="Specific_Interaction"/><entity charOffset="85:97" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.5" text="desmopressin" type="Drug"><Normalization><mmtx cui="C0011701" phraseText="interfere with the V2-agonist activity of desmopressin" preferredWord="desmopressin" semType="phsu, aapp, horm"/><RxNorm RxCui="3251"/></Normalization></entity><drugClassMembership drug="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.2" drugClass="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.1"/><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.4"><relations><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.2" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.5" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.122.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123" lineNumber="144" text="In a male subject with mild Von Willebrand (vW) disease, intravenous infusion of dDAVP 2 hours after administration of oral tolvaptan did not produce the expected increases in vW Factor Antigen or Factor VIII activity. " type="regular"><entity charOffset="134:217" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.1" text="did not produce the expected increases in vW Factor Antigen or Factor VIII activity" type="Specific_Interaction"/><entity charOffset="23:55" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.2" text="mild Von Willebrand (vW) disease" type="SPAN"><Normalization><mmtx cui="C0042974" phraseText="with mild Von Willebrand (vW) disease," preferredWord="von Willebrand Disease" semType="dsyn"/></Normalization></entity><entity charOffset="3:17" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.3" text="a male subject" type="SPAN"/><entity charOffset="57:86" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.4" text="intravenous infusion of dDAVP" type="Drug"><Normalization><mmtx cui="C0701195" phraseText="intravenous infusion of dDAVP 2 hours" preferredWord="DDAVP" semType="phsu, aapp, horm"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="119:133" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.5" text="oral tolvaptan" type="Drug"><Normalization><mmtx cui="C1176308" phraseText="of oral tolvaptan" preferredWord="tolvaptan" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.1"><relations><relation type="hasContext"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.2"/></relation><relation type="hasEvidence"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.2" ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.4" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.5" evidence="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.3" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.123.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.124" lineNumber="144" text="It is not recommended to administer SAMSCA with a V2-agonist." type="regular"><entity charOffset="6:21" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.124.e.1" text="not recommended" type="Caution_Interaction"/><entity charOffset="50:60" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.124.e.2" text="V2-agonist" type="Drug_Class"><Normalization><mmtx cui="C2987634" phraseText="SAMSCA with a V2-agonist." preferredWord="Agonist" semType="phsu"/><RxNorm RxCui="608609"/></Normalization></entity><entity charOffset="36:42" id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.124.e.3" text="SAMSCA" type="Drug"><Normalization><mmtx cui="C2710117" phraseText="SAMSCA with a V2-agonist." preferredWord="Samsca" semType="phsu, orch"/><RxNorm RxCui="849828"/></Normalization></entity><drugInteraction id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.124.ddi.1"><interaction trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.124.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.124.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.124.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.124.e.3" e2="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.124.e.2" trigger="Dailymed.5526617c-c7b9-4556-886d-729bbabbc566.s.124.e.1" type="Caution_Interaction"/></sentence><positiveExamples number="33"/><negativeExamples number="143"/></document>